Pengcheng Ma

1.9k total citations
102 papers, 1.3k citations indexed

About

Pengcheng Ma is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Pengcheng Ma has authored 102 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 18 papers in Genetics and 14 papers in Pharmacology. Recurrent topics in Pengcheng Ma's work include Ubiquitin and proteasome pathways (9 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Epigenetics and DNA Methylation (7 papers). Pengcheng Ma is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Epigenetics and DNA Methylation (7 papers). Pengcheng Ma collaborates with scholars based in China, Thailand and United States. Pengcheng Ma's co-authors include Bingyu Mao, Xuetao Cao, Qiuyan Liu, Taoyong Chen, Chaocui Li, Qinghua Kong, Guoyou Chen, Li Ding, Yuping Cao and Huishan Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Pengcheng Ma

90 papers receiving 1.3k citations

Peers

Pengcheng Ma
Comparison fields: 5 of 130
  • Molecular Biology 739
  • Genetics 218
  • Oncology 182
  • Complementary and alternative medicine 175
  • Immunology 160
Replace Qing Sun with:
Qing Sun China
Yu‐Wen Su China
Lan Lan China
Lisha Zhang China
Pengxin Qiu China
Toshinori Nakagawa Japan
Zhaiyi Zhang China
Chunlei Yu China
Qing Sun China View profile →
Citations per field, relative to Pengcheng Ma
Pengcheng Ma · 1×
Citations per year, relative to Pengcheng Ma
Pengcheng Ma · 1×

Countries citing papers authored by Pengcheng Ma

Since Specialization
Citations

This map shows the geographic impact of Pengcheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Ma more than expected).

Fields of papers citing papers by Pengcheng Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengcheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Ma. The network helps show where Pengcheng Ma may publish in the future.

Co-authorship network of co-authors of Pengcheng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Pengcheng Ma. A scholar is included among the top collaborators of Pengcheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengcheng Ma. Pengcheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 0
3 0
4 1
5 0
6 3
7 4
8 3
9 25
10 26
11 18
12 18
13 31
14 8
15 1
16 109
17 8
18 21
19 30
20 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026